OTCMKTS:RCDTF

Recordati Industria Chimica e Farmaceutica Stock Forecast, Price & News

$53.65
0.00 (0.00 %)
(As of 04/12/2021 12:00 AM ET)
Add
Compare
Today's Range
$53.65
Now: $53.65
$53.65
50-Day Range
$51.69
MA: $53.05
$53.65
52-Week Range
$36.50
Now: $53.65
$55.87
VolumeN/A
Average Volume8,400 shs
Market Capitalization$11.22 billion
P/E Ratio25.79
Dividend YieldN/A
Beta0.3
Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals worldwide. The company offers pharmaceuticals in various therapeutic areas, including cardiovascular, cosmetics, dermatology, dietary supplements, gynecology and obstetrics, medical devices, musculo-skeletal disorders and analgesia, over the counter/non-prescription pharmaceuticals, urology, allergy, anti-infectives, central nervous system, endocrinology, gastrointestinal, nutrition and related products, pain management/inflammation, generics, pneumology, antipyretics and cold preparations, endocrinology, oncology, respiratory, and medical devices, as well as ear, nose, and throat. It also provides pharmaceutical chemicals, such as chemical syntheses, active pharmaceutical ingredients, and intermediates. The company was founded in 1926 and is headquartered in Milan, Italy. Recordati Industria Chimica e Farmaceutica S.p.A. is a subsidiary of Fimei - Finanziaria Industriale Mobiliare ed Immobiliare S.P.A.

Industry, Sector and Symbol

Industry Private households
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:RCDTF
Previous SymbolNASDAQ:RCDTF
CUSIPN/A
CIKN/A
Phone390-248-7871
Employees4,486
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.64 billion
Cash Flow$2.35 per share
Book Value$6.42 per share

Profitability

Net Income$413.08 million

Miscellaneous

Market Cap$11.22 billion
Next Earnings Date5/6/2021 (Estimated)
OptionableNot Optionable

Headlines

5 High-Quality Stocks in the Mediterranean
December 17, 2020 |  finance.yahoo.com
Recordati Industria Chimica e Farmaceutica SpA
October 23, 2020 |  bloomberg.com
See More Headlines

MarketRank

Overall MarketRank

0.71 out of 5 stars

Medical Sector

1255th out of 2,016 stocks

Private Households Industry

222nd out of 378 stocks

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -
$53.65
0.00 (0.00 %)
(As of 04/12/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive RCDTF News and Ratings via Email

Sign-up to receive the latest news and ratings for RCDTF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) Frequently Asked Questions

Is Recordati Industria Chimica e Farmaceutica a buy right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Recordati Industria Chimica e Farmaceutica in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Recordati Industria Chimica e Farmaceutica stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in RCDTF, but not buy additional shares or sell existing shares.
View analyst ratings for Recordati Industria Chimica e Farmaceutica
or view top-rated stocks.

What stocks does MarketBeat like better than Recordati Industria Chimica e Farmaceutica?

Wall Street analysts have given Recordati Industria Chimica e Farmaceutica a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Recordati Industria Chimica e Farmaceutica wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Recordati Industria Chimica e Farmaceutica?

Recordati Industria Chimica e Farmaceutica saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 487,300 shares, an increase of 35.2% from the March 15th total of 360,400 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is currently ∞ days.
View Recordati Industria Chimica e Farmaceutica's Short Interest
.

When is Recordati Industria Chimica e Farmaceutica's next earnings date?

Recordati Industria Chimica e Farmaceutica is scheduled to release its next quarterly earnings announcement on Thursday, May 6th 2021.
View our earnings forecast for Recordati Industria Chimica e Farmaceutica
.

How has Recordati Industria Chimica e Farmaceutica's stock been impacted by COVID-19?

Recordati Industria Chimica e Farmaceutica's stock was trading at $40.40 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, RCDTF stock has increased by 32.8% and is now trading at $53.6477.
View which stocks have been most impacted by COVID-19
.

Who are Recordati Industria Chimica e Farmaceutica's key executives?

Recordati Industria Chimica e Farmaceutica's management team includes the following people:
  • Mr. Andrea Recordati, CEO & Director (Age 50)
  • Mr. Fritz Squindo, Group GM & Exec. Director (Age 65)
  • Mr. Luigi Felice La Corte, Group Chief Financial Officer (Age 52)
  • Ms. Federica De Medici, Director of Investor Relations & Corp. Communications
  • Ms. Daria Ghidoni, VP of Corp. Legal Counsel
  • Mr. Gabriele Finzi, VP of Corp. Devel. & Licensing
  • Mr. Giuseppe Gualazzini, Sr. VP of Group HR (Age 62)
  • Mr. Corrado Castellucci, Exec. VP of Rare Diseases Bus. Unit
  • Ms. Luisa Mainoli, Sr. VP of Group Fin.
  • Mr. Roberto Teruzzi, Exec. VP of Group Industrial Operations

Who are some of Recordati Industria Chimica e Farmaceutica's key competitors?

What is Recordati Industria Chimica e Farmaceutica's stock symbol?

Recordati Industria Chimica e Farmaceutica trades on the OTCMKTS under the ticker symbol "RCDTF."

How do I buy shares of Recordati Industria Chimica e Farmaceutica?

Shares of RCDTF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Recordati Industria Chimica e Farmaceutica's stock price today?

One share of RCDTF stock can currently be purchased for approximately $53.65.

How much money does Recordati Industria Chimica e Farmaceutica make?

Recordati Industria Chimica e Farmaceutica has a market capitalization of $11.22 billion and generates $1.64 billion in revenue each year. The company earns $413.08 million in net income (profit) each year or $1.98 on an earnings per share basis.

How many employees does Recordati Industria Chimica e Farmaceutica have?

Recordati Industria Chimica e Farmaceutica employs 4,486 workers across the globe.

What is Recordati Industria Chimica e Farmaceutica's official website?

The official website for Recordati Industria Chimica e Farmaceutica is www.recordati.com.

Where are Recordati Industria Chimica e Farmaceutica's headquarters?

Recordati Industria Chimica e Farmaceutica is headquartered at Via Matteo Civitali 1, Milano L6, 20148.

How can I contact Recordati Industria Chimica e Farmaceutica?

Recordati Industria Chimica e Farmaceutica's mailing address is Via Matteo Civitali 1, Milano L6, 20148. The company can be reached via phone at 390-248-7871 or via email at [email protected]


This page was last updated on 4/13/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.